Platforms
ActiveCampaign for Supplement & Peptide Brands (2026)
ActiveCampaign for supplements and peptide brands: restricted-industry risk, automation strengths, pricing, and what we'd run instead.
· 4 min read
TL;DR: ActiveCampaign has one of the deepest automation engines in email marketing — genuinely strong branching logic and lead scoring. It also restricts high-risk categories in its terms, same as Klaviyo and Mailchimp, and we don't recommend it as a default for peptide or GLP-1 brands. Self-hosted FluentCRM removes the risk entirely; Sendlane is our hosted fallback when self-hosting isn't ready yet.
What ActiveCampaign is and who it's built for
ActiveCampaign started as a CRM-and-automation platform for B2B and services businesses before building out ecommerce features to compete with Klaviyo. Its core strength is still visible in that history: the automation builder handles branching logic, conditional splits, and lead scoring with more depth than most ecommerce-native ESPs bother to build.
For businesses running complex, multi-path nurture sequences — not just cart-abandonment and post-purchase flows — that depth is a real draw. It's why agencies outside ecommerce reach for it first.
Does ActiveCampaign allow peptides and supplements?
Not comfortably, and the ambiguity here works against you rather than for you. ActiveCampaign's acceptable-use policy restricts categories that overlap with peptide and research-chemical marketing, but because the platform's core audience skews B2B and services, that language wasn't written with an ecommerce supplement brand's specific situation in mind. That gap doesn't create safety — it creates unpredictability. You can't reliably forecast how an account reviewer unfamiliar with the category will read your product pages and email copy.
Supplements more broadly sit in a grayer zone, the same as with most mainstream ESPs. Peptides specifically have less room for interpretation.
Strengths for a peptide-adjacent brand specifically
Automation depth that's hard to match elsewhere. If your flow strategy needs real branching — different paths by engagement score, purchase history, and behavior, not just a linear welcome series — ActiveCampaign's builder is built for exactly that.
CRM and sales-pipeline features built in. Useful if you run any direct or wholesale sales motion alongside DTC email.
Strong deliverability reputation generally. ActiveCampaign maintains solid sending infrastructure for accounts that stay within policy.
Weaknesses to know going in
Restricted-industries enforcement is unpredictable for this category. The platform wasn't built with ecommerce supplement or peptide brands as a primary use case, so account review can go either way.
Steeper learning curve than Klaviyo or Omnisend. The automation depth that's a strength for power users is a real onboarding cost for a small team without a dedicated email hire.
Ecommerce-specific templates are thinner than Klaviyo's. You get more automation logic and less out-of-the-box ecommerce tooling.
Ban and suspension risk
Real, and worth taking seriously. ActiveCampaign restricts high-risk categories in its terms the same as Klaviyo and Mailchimp, and an account review that goes the wrong way costs you the list, the automation history, and the lead scoring you've built up — often with little warning. The only structural fix, rather than hoping an account stays under the radar, is self-hosted FluentCRM, where there's no platform account for a policy team to review in the first place.
Pricing posture
ActiveCampaign prices by contact count and feature tier, and the tiers with the automation depth this platform is known for sit above entry-level pricing. Broadly comparable to Klaviyo at similar list sizes once you're in a tier with real branching logic. Check ActiveCampaign's current pricing page for exact numbers.
Our verdict and what we'd run instead
Our default recommendation, in order:
- Self-hosted FluentCRM — the same branching-automation depth ActiveCampaign is known for, with zero suspension risk because there's no account to suspend.
- Sendlane — our hosted pick when self-hosting isn't feasible yet, built to tolerate this category directly.
- Omnisend, occasionally — for brands closer to general supplement DTC than pure peptide sending.
ActiveCampaign doesn't make that list for a peptide or GLP-1 brand. The automation power is real. It's not worth the category risk when FluentCRM gets you comparable branching logic without a policy team standing between you and your list.
ActiveCampaign vs the field
| Factor | ActiveCampaign | Sendlane | FluentCRM (self-hosted) |
|---|---|---|---|
| Peptide/high-risk tolerance | Restricted industries, unpredictable review | Built for it | No policy to violate — no account exists |
| Ban/suspension risk | Real, documented in adjacent categories | Lower than mainstream ESPs, not zero | None |
| Automation depth | Among the deepest available | Solid, covers most needs | Depends on setup, can match with FluentCRM automations |
| Ease of setup | Steeper learning curve | Fast, moderate learning curve | Slower — server, relay, DNS |
| Best for | Complex B2B/services automation | Fast launch without ban risk | Brands ready to own their stack |
Where does this leave you
If you're running a services or B2B business with light ecommerce and no peptide exposure, ActiveCampaign's automation depth is a legitimate reason to pick it. If peptides or GLP-1 products are the business, that same depth is available without the account risk — on FluentCRM, with us handling the build. We lay out the full platform landscape in best email platforms for peptide and supplement brands, and how ban risk compares platform to platform in our Klaviyo battlecard. The complete flow-by-flow strategy is in email marketing for peptide brands.
We've taken peptide and GLP-1 brands from startup to seven and eight figures running branching automation on infrastructure that can't be taken away from them. If you'd rather hand the platform decision off entirely, that's our done-for-you email service.
Frequently asked questions
- Can I use ActiveCampaign for supplements or peptides?
- You can, but we don't recommend it as a default. ActiveCampaign maintains a restricted-industries policy that peptide and research-chemical marketing routinely runs into, and its account review has, in our experience, been unpredictable about when it triggers.
- Is ActiveCampaign good for peptide brands specifically?
- Its automation engine is genuinely strong — arguably deeper than Klaviyo's for complex branching logic. That strength doesn't offset the category risk. We'd rather a peptide brand run that automation depth on infrastructure that can't suspend the account.
- What happens if ActiveCampaign suspends my account?
- You lose access to your contact list, automation workflows, and send history, typically with limited notice. Rebuilding that from scratch — flows, tags, scoring rules — is a heavier loss than most founders expect until it happens.
- ActiveCampaign vs Klaviyo — which is riskier for peptide brands?
- Both restrict this category. ActiveCampaign markets itself more toward B2B and services, which means its restricted-industries language wasn't written with ecommerce supplement brands specifically in mind — that ambiguity cuts both ways and doesn't make it safer.
- How much does ActiveCampaign cost?
- ActiveCampaign prices by contact count and feature tier, generally competitive with Klaviyo at similar list sizes. Check ActiveCampaign's current pricing directly — we don't cite figures that go stale.
- Is it legal to market peptides through ActiveCampaign?
- Legality and platform policy are separate questions. Nothing about using ActiveCampaign is illegal — the exposure is contractual, from violating its acceptable-use policy, not regulatory.
- What's a safer alternative to ActiveCampaign for a peptide brand?
- Self-hosted FluentCRM removes suspension risk entirely — there's no account for a policy team to review. Sendlane is our hosted alternative, built to tolerate this category instead of restricting it.